跳至主要内容
临床试验/NCT01784471
NCT01784471已完成不适用

A Pilot Study to Assess the Use of the Magic Foot in the Improvement of Subjective and Objective Parameters in Subjects With Foot Symptoms as a Result of Diabetes or Peripheral Vascular Disease.

Yaffa Golan, Ltd.2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2012年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
34
试验地点
2
主要终点
Changes in total peripheral resistance as assessed by impedance cardiography (ICG) from baseline to day 30

研究概览

简要总结

This is a single-arm, single-center, open-label, pilot study . 30 subjects with foot symptoms attributable to diabetes or peripheral vascular disease will be screened . Subjects meeting inclusion criteria will sign informed consent and enrolled. All 30 subjects will be treated with the Magic Foot™.

If there is any significant improvement in ICG or foot symptoms as obtained from self evaluation questionnaire, a further 30 subjects will be enrolled.

详细描述

This is a single-arm, single-center, open-label, pilot study . 30 subjects with foot symptoms attributable to diabetes or peripheral vascular disease will be screened and enrolled. Subjects meeting inclusion criteria will sign informed consent. They will undergo a full examination including blood pressure measurement, heart rate and ECG.

A self evaluation questionnaire relating to foot and sleep disorder symptoms will be completed.

A baseline screening ICG will be performed to measure total peripheral resistance CO (Cardiac Output) and SV (Stroke Volume).

ABI will be performed. The investigational product will be used for 30 minutes and ICG will be repeated.

Each subject will be provided with a size appropriate pair of Magic Foot™ to use at home.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject over the age of 18 with Type 1 / Type 2 diabetes or with PVD (Peripheral vascular disease) or ABI < 0.9 with foot symptoms.
  • Subject able and willing to comply with the requirements of the protocol.
  • Subject able to understand and sign written informed consent to participate in the study.
  • One or more of the following foot symptoms:
  • Pain at rest
  • Pain on activity
  • Nocturnal feet pain
  • Burning sensations
  • Loss of sensation
  • Cold feet
  • Recurrent ulcers , wounds , injuries - longtime to heal

排除标准

  • Active foot infection
  • Open ulcer in shoe area
  • Subjects with unstable or lifethreatening conditions
  • History of malignancy
  • Active Charcot arthropathy
  • Impaired cognitive function -unable to sign informed consent
  • History of drug or alcohol abuse
  • Subject currently enrolled or has not yet completed other investigational device or drug study or subject is receiving other investigational agents.
  • Other conditions based on Principle Investigators judgement

结局指标

主要结局

Changes in total peripheral resistance as assessed by impedance cardiography (ICG) from baseline to day 30

时间窗: From baseline to day 30.

次要结局

未报告次要终点

研究者

发起方
Yaffa Golan, Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Open-label Pilot Study to Assess the Use of Magic... | 临床试验